Ghana Marks 20 Years of HIV Antiretroviral Treatment

ghana-marks-20-years-of-hiv-antiretroviral-treatment

Ghana commemorated two decades of HIV antiretroviral treatment with a launch event themed “20 Years of HIV Antiretroviral Treatment in Ghana: Celebrating the Progress, Ending the Epidemic.” The event, organized by the Ghana Health Service and supported by health partners, highlighted the nation’s strides in combating the HIV/AIDS pandemic.

Dr. Patrick Kuma-Aboagye, Director-General of the Ghana Health Service, reflected on Ghana’s journey since diagnosing its first AIDS case in 1986. He emphasized the pivotal role of programs like the National AIDS/STI Control Programme (NACP) and the National Advisory Council on AIDS (NACA) in curbing the spread of HIV.

Dr. Kuma-Aboagye acknowledged the significant decline in HIV-related deaths and new infections, attributing it to improved access to life-saving therapy. However, he cautioned against lingering challenges such as stigma, discrimination, and the need for sustained funding and medical infrastructure.

In his welcome address, Dr. Franklin Asiedu-Bekoe, Director of Public Health, underscored the transformative impact of antiretroviral therapy on HIV/AIDS care in Ghana. He praised the resilience of individuals living with HIV and advocacy groups in advocating for equitable access to treatment.

Despite progress, Dr. Asiedu-Bekoe stressed the importance of addressing remaining barriers to ensure universal access to medication. He called for concerted efforts to tackle stigma, discrimination, and inequality, emphasizing the collective responsibility to pave the way for a society free from the HIV pandemic.

The event highlighted the evolution of antiretroviral medication over the past two decades, offering hope and improving the quality of life for those affected by HIV/AIDS. As Ghana commemorates this milestone, it reaffirms its commitment to sustaining progress and striving for an HIV-free future.




0 Comments

No Comments available. Be the first to comment on this post

Leave a Comment

Your email address will not be published. Required fields are marked *

Add Comment *

Name*

Email*